保全颜面：寻求面部移植终身免疫抑制的替代方案。 - Suppr

Suppr

超能文献

Saving face: The search for alternatives to life-long immunosuppression for face transplants.

作者信息

Keener Amanda B

出版信息

Nat Med. 2016 May 5;22(5):448-9. doi: 10.1038/nm0516-448.

DOI:10.1038/nm0516-448

PMID:27149211

Abstract

摘要

相似文献

Saving face: The search for alternatives to life-long immunosuppression for face transplants.

Nat Med. 2016 May 5;22(5):448-9. doi: 10.1038/nm0516-448.

Current concepts and future challenges in facial transplantation.

Clin Plast Surg. 2009 Jul;36(3):507-21. doi: 10.1016/j.cps.2009.02.006.

Achieving immune tolerance in hand and face transplantation: a realistic prospect?

Immunotherapy. 2014;6(5):499-502. doi: 10.2217/imt.14.29.

Facial transplantation: the first 9 years.

Lancet. 2014 Dec 13;384(9960):2153-63. doi: 10.1016/S0140-6736(13)62632-X. Epub 2014 Apr 27.

Exploring cell-based tolerance strategies for hand and face transplantation.

Expert Rev Clin Immunol. 2015;11(11):1189-204. doi: 10.1586/1744666X.2015.1078729. Epub 2015 Aug 13.

Facial Transplantation.

Facial Plast Surg Clin North Am. 2016 Aug;24(3):367-77. doi: 10.1016/j.fsc.2016.03.013.

Reporting Practices on Immunosuppression and Rejection Management in Face Transplantation: A Systematic Review.

J Reconstr Microsurg. 2019 Nov;35(9):652-661. doi: 10.1055/s-0039-1691787. Epub 2019 Jun 6.

Face transplant: a paradigm change in facial reconstruction.

J Craniofac Surg. 2012 Jan;23(1):250-3. doi: 10.1097/SCS.0b013e318241c10b.

Vascularized Composite Allotransplantation and Immunobiology: The Next Frontier.

Plast Reconstr Surg. 2021 Jun 1;147(6):1092e-1093e. doi: 10.1097/PRS.0000000000007954.

The impact of current immunosuppression strategies in renal transplantation on the field of reconstructive transplantation.

J Reconstr Microsurg. 2012 Jan;28(1):7-19. doi: 10.1055/s-0031-1285988. Epub 2011 Aug 12.

引用本文的文献

Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.

Sci Rep. 2019 Jun 25;9(1):9269. doi: 10.1038/s41598-019-45759-y.

本文引用的文献

Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.

Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):299-310. doi: 10.1007/s00005-015-0380-8. Epub 2015 Dec 26.

Exploring cell-based tolerance strategies for hand and face transplantation.

Expert Rev Clin Immunol. 2015;11(11):1189-204. doi: 10.1586/1744666X.2015.1078729. Epub 2015 Aug 13.

Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.

Transplantation. 2015 Sep;99(9):1765-73. doi: 10.1097/TP.0000000000000731.

Vascularized composite allograft tolerance across MHC barriers in a large animal model.

Am J Transplant. 2014 Feb;14(2):343-55. doi: 10.1111/ajt.12560. Epub 2014 Jan 9.

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.

Ann Surg. 2013 Feb;257(2):345-51. doi: 10.1097/SLA.0b013e31826d90bb.

An act of tolerance.

Nat Med. 2012 Jan 6;18(1):12-6. doi: 10.1038/nm0112-12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Saving face: The search for alternatives to life-long immunosuppression for face transplants.

Nat Med. 2016 May 5;22(5):448-9. doi: 10.1038/nm0516-448.

Current concepts and future challenges in facial transplantation.

Clin Plast Surg. 2009 Jul;36(3):507-21. doi: 10.1016/j.cps.2009.02.006.

Achieving immune tolerance in hand and face transplantation: a realistic prospect?

Immunotherapy. 2014;6(5):499-502. doi: 10.2217/imt.14.29.

Facial transplantation: the first 9 years.

Lancet. 2014 Dec 13;384(9960):2153-63. doi: 10.1016/S0140-6736(13)62632-X. Epub 2014 Apr 27.

Exploring cell-based tolerance strategies for hand and face transplantation.

Expert Rev Clin Immunol. 2015;11(11):1189-204. doi: 10.1586/1744666X.2015.1078729. Epub 2015 Aug 13.

Facial Transplantation.

Facial Plast Surg Clin North Am. 2016 Aug;24(3):367-77. doi: 10.1016/j.fsc.2016.03.013.

Reporting Practices on Immunosuppression and Rejection Management in Face Transplantation: A Systematic Review.

J Reconstr Microsurg. 2019 Nov;35(9):652-661. doi: 10.1055/s-0039-1691787. Epub 2019 Jun 6.

Face transplant: a paradigm change in facial reconstruction.

J Craniofac Surg. 2012 Jan;23(1):250-3. doi: 10.1097/SCS.0b013e318241c10b.

Vascularized Composite Allotransplantation and Immunobiology: The Next Frontier.

Plast Reconstr Surg. 2021 Jun 1;147(6):1092e-1093e. doi: 10.1097/PRS.0000000000007954.

The impact of current immunosuppression strategies in renal transplantation on the field of reconstructive transplantation.

J Reconstr Microsurg. 2012 Jan;28(1):7-19. doi: 10.1055/s-0031-1285988. Epub 2011 Aug 12.

引用本文的文献

Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.

Sci Rep. 2019 Jun 25;9(1):9269. doi: 10.1038/s41598-019-45759-y.

本文引用的文献

Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.

Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):299-310. doi: 10.1007/s00005-015-0380-8. Epub 2015 Dec 26.

Exploring cell-based tolerance strategies for hand and face transplantation.

Expert Rev Clin Immunol. 2015;11(11):1189-204. doi: 10.1586/1744666X.2015.1078729. Epub 2015 Aug 13.

Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.

Transplantation. 2015 Sep;99(9):1765-73. doi: 10.1097/TP.0000000000000731.

Vascularized composite allograft tolerance across MHC barriers in a large animal model.

Am J Transplant. 2014 Feb;14(2):343-55. doi: 10.1111/ajt.12560. Epub 2014 Jan 9.

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.

Ann Surg. 2013 Feb;257(2):345-51. doi: 10.1097/SLA.0b013e31826d90bb.

An act of tolerance.

Nat Med. 2012 Jan 6;18(1):12-6. doi: 10.1038/nm0112-12.